350,000 courses of Pfizer's COVID-19 drug Paxlovid to arrive by June

Taiwan has signed a second contract with American drugmaker Pfizer to procure 350,000 courses of their COVID-19 treatment medicine Paxlovid, which will arrive by the end of June, Minister of Health and Welfare Chen Shih-chung (陳時中) said Monday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)